CN101245061B - N-(5-氨基-2-甲基苯基)-4-(3-吡啶基)-2-嘧啶胺类一氧化氮供体型衍生物,制备方法及其用途 - Google Patents
N-(5-氨基-2-甲基苯基)-4-(3-吡啶基)-2-嘧啶胺类一氧化氮供体型衍生物,制备方法及其用途 Download PDFInfo
- Publication number
- CN101245061B CN101245061B CN2008100001174A CN200810000117A CN101245061B CN 101245061 B CN101245061 B CN 101245061B CN 2008100001174 A CN2008100001174 A CN 2008100001174A CN 200810000117 A CN200810000117 A CN 200810000117A CN 101245061 B CN101245061 B CN 101245061B
- Authority
- CN
- China
- Prior art keywords
- methyl
- amino
- phenyl
- compound
- pyrimidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100001174A CN101245061B (zh) | 2007-02-13 | 2008-01-03 | N-(5-氨基-2-甲基苯基)-4-(3-吡啶基)-2-嘧啶胺类一氧化氮供体型衍生物,制备方法及其用途 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710056796.2 | 2007-02-13 | ||
CN200710056796 | 2007-02-13 | ||
CN2008100001174A CN101245061B (zh) | 2007-02-13 | 2008-01-03 | N-(5-氨基-2-甲基苯基)-4-(3-吡啶基)-2-嘧啶胺类一氧化氮供体型衍生物,制备方法及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101245061A CN101245061A (zh) | 2008-08-20 |
CN101245061B true CN101245061B (zh) | 2012-09-19 |
Family
ID=39945768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100001174A Active CN101245061B (zh) | 2007-02-13 | 2008-01-03 | N-(5-氨基-2-甲基苯基)-4-(3-吡啶基)-2-嘧啶胺类一氧化氮供体型衍生物,制备方法及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101245061B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102372690B (zh) * | 2010-08-20 | 2014-05-28 | 成都地奥制药集团有限公司 | 用于合成伊马替尼的中间体及其在伊马替尼合成中的应用 |
CN104292210B (zh) * | 2013-07-15 | 2017-11-10 | 天津药物研究院 | 含吡啶的一氧化氮供体类化合物、其制备方法及用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1077713A (zh) * | 1992-04-03 | 1993-10-27 | 希巴-盖吉股份公司 | 嘧啶衍生物及其制备方法 |
CN1646519A (zh) * | 2002-01-23 | 2005-07-27 | 诺瓦提斯公司 | N-苯基-2-嘧啶-胺衍生物的n-氧化物 |
-
2008
- 2008-01-03 CN CN2008100001174A patent/CN101245061B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1077713A (zh) * | 1992-04-03 | 1993-10-27 | 希巴-盖吉股份公司 | 嘧啶衍生物及其制备方法 |
CN1646519A (zh) * | 2002-01-23 | 2005-07-27 | 诺瓦提斯公司 | N-苯基-2-嘧啶-胺衍生物的n-氧化物 |
Also Published As
Publication number | Publication date |
---|---|
CN101245061A (zh) | 2008-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6080947B2 (ja) | Abl1、abl2およびbcr−abl1の活性を阻害するための化合物および組成物 | |
JP6078640B2 (ja) | Abl1、abl2およびbcr−abl1の活性を阻害するためのベンズアミド誘導体 | |
US9029386B2 (en) | Pyridine derivatives useful as kinase inhibitors | |
JP7191799B2 (ja) | ピリミジン化合物及びその医薬用途 | |
US20160039793A1 (en) | Phosphatidylinositol 3-kinase inhibitors | |
JP6696670B2 (ja) | ピリジニルアミノピリミジン誘導体の塩、その製造方法及びその使用 | |
JP6671552B2 (ja) | 新規のピリミジン化合物、それを調製する方法、及び癌及び炎症性疾患を予防又は治療するための該ピリミジン化合物を含有する医薬組成物 | |
JP6855636B2 (ja) | イミダゾリジン化合物 | |
EA026412B1 (ru) | НОВЫЕ СОЕДИНЕНИЯ 3,5-ДИЗАМЕЩЕННОГО-3H-ИМИДАЗО[4,5-b]ПИРИДИНА И 3,5-ДИЗАМЕЩЕННОГО-3H-[1,2,3]ТРИАЗОЛО[4,5-b]ПИРИДИНА КАК МОДУЛЯТОРЫ c-MET ПРОТЕИНКИНАЗ | |
CN101503402A (zh) | 2-苯胺嘧啶衍生物及其制备和用途 | |
ES2927959T3 (es) | Compuestos de imidazol heterocíclicos, composiciones farmacéuticas de los mismos, método de preparación de los mismos y uso de los mismos | |
US20190169124A1 (en) | New derivatives of indole for the treatment of cancer, viral infections and lung diseases | |
CN101245061B (zh) | N-(5-氨基-2-甲基苯基)-4-(3-吡啶基)-2-嘧啶胺类一氧化氮供体型衍生物,制备方法及其用途 | |
CN101225085B (zh) | 苯基呋咱氮类一氧化氮供体型2-苯胺嘧啶衍生物、其制备方法、含有该化合物的组合物及其用途 | |
US9550764B2 (en) | Fused heterocyclic compounds and their use | |
KR102440296B1 (ko) | 피라졸기로 치환된 피리미딘 유도체 화합물, 이의 광학이성질체, 또는 이의 약학적으로 허용 가능한 염, 및 이를 유효성분으로 포함하는 암 예방 또는 치료용 조성물 | |
CN114630819B (zh) | 用于预防或治疗癌症的苯甲酰胺衍生物、其制备方法以及包含其作为活性成分的药物组合物 | |
US11407760B2 (en) | Dioxinoquinoline compounds, preparation method and uses thereof | |
CN107501283B (zh) | 取代芳甲杂基取代苯胺基缩乙二醇醚环代喹唑啉的制备及肿瘤治疗药物应用 | |
KR102383561B1 (ko) | 테트라히드로이소퀴놀린기로 치환된 피리미딘 유도체 화합물, 이의 광학이성질체, 또는 이의 약학적으로 허용 가능한 염, 및 이를 유효성분으로 포함하는 암 예방 또는 치료용 조성물 | |
CN105153160A (zh) | 一种no供体型哌嗪类苦参碱衍生物、其制备方法以及用途 | |
CN101701018A (zh) | 2-(4-氨基喹唑啉基)苯并[d]噻唑类衍生物及其用途 | |
CN104370898A (zh) | 咪唑并[1,2-a]吡啶类化合物及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: TASLY HOLDING GROUP CO., LTD. Free format text: FORMER NAME: TIANJIN TASLY GROUP CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee after: TASLY HOLDING GROUP CO., LTD. Address before: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee before: Tianjin Tasly Group Co., Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20080820 Assignee: Tianshili Diyi Pharmaceutical Ind Co., Ltd., Jiangsu Assignor: TASLY HOLDING GROUP CO., LTD. Contract record no.: 2015320000356 Denomination of invention: Medicine for curing cancer, the preparation process and the application thereof Granted publication date: 20120919 License type: Exclusive License Record date: 20150521 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160727 Address after: 223003 Jiangsu Huaian Qingpu Industrial Park, Chaoyang Road No. 168 Patentee after: Tianshili Diyi Pharmaceutical Ind Co., Ltd., Jiangsu Address before: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee before: TASLY HOLDING GROUP CO., LTD. |